D Prokopowicz Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

9/2003	The incidence of HLA DRB1*0103 in ulcerative colitis patients in north-eastern Poland.
1/2001	Plasma and mucosal prostaglandin E2 as a surrogate marker of ulcerative colitis activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Prokopowicz Research Topics

Disease

7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2004 - 01/2000
6	Ulcerative Colitis 12/2005 - 06/2000
5	Infections 04/2008 - 01/2000
4	Hepatitis B 01/2003 - 01/2000
3	Inflammation (Inflammations) 06/2001 - 06/2000
3	Liver Diseases (Liver Disease) 05/2001 - 06/2000
2	Disease Progression 01/2005 - 09/2003
2	Chronic Hepatitis B 01/2005 - 01/2004
2	Hepatitis C 12/2004 - 11/2004
2	Chronic Hepatitis C 12/2004 - 01/2003
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2003 - 01/2001
2	Chronic Hepatitis (Chronic Active Hepatitis) 05/2001 - 11/2000
1	Hepatic Encephalopathy 11/2003
1	Disease Susceptibility (Diathesis) 09/2003
1	Megacolon 09/2003
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2003
1	Wounds and Injuries (Trauma) 03/2001
1	Alveolar echinococcosis 01/2001
1	Renal Colic 01/2001
1	Nephrolithiasis 01/2001
1	Hepatic Insufficiency 11/2000
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2000
1	Extrahepatic Cholestasis 06/2000
1	Fibrosis (Cirrhosis) 06/2000
1	Autoimmune Hepatitis 06/2000
1	Hepatitis A (Hepatitis, Infectious) 06/2000
1	Human Influenza (Influenza) 05/2000
1	Guillain-Barre Syndrome 05/2000
1	Giardiasis 01/2000
1	Lyme Disease (Disease, Lyme) 01/2000
1	Thrombocytopenia (Thrombopenia) 01/2000

Drug/Important Bio-Agent (IBA)

4	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2005 - 06/2000
3	Protons (Proton)IBA 12/2004 - 01/2001
3	Indicators and Reagents (Reagents)IBA 06/2001 - 06/2000
3	AntibodiesIBA 01/2001 - 01/2000
3	AntigensIBA 01/2001 - 01/2000
2	Dinoprostone (PGE2)FDA Link 12/2005 - 01/2001
2	Biomarkers (Surrogate Marker)IBA 01/2001 - 11/2000
1	RNA (Ribonucleic Acid)IBA 04/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2005
1	Hepatitis B e AntigensIBA 01/2004
1	Antiviral Agents (Antivirals)IBA 01/2004
1	Hyaluronic Acid (Hyaluronan)IBA 01/2004
1	Lamivudine (Epivir)FDA Link 01/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2003
1	Isoantigens (Alloantigen)IBA 09/2003
1	HLA-DRB1 Chains (HLA DRB1)IBA 09/2003
1	Histocompatibility Antigens Class IIIBA 09/2003
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2003
1	VaccinesIBA 01/2003
1	Thrombin FDA Link 05/2001
1	P-SelectinIBA 05/2001
1	beta-ThromboglobulinIBA 05/2001
1	Extracellular Matrix ProteinsIBA 03/2001
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2001
1	Indinavir (Crixivan)FDA Link 01/2001
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2001
1	EnzymesIBA 11/2000
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 06/2000
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2000
1	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2000
1	Misoprostol (Cytotec)FDA LinkGeneric 03/2000
1	NeopterinIBA 01/2000
1	Metronidazole (Metric)FDA LinkGeneric 01/2000
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 01/2000
1	AutoantibodiesIBA 01/2000
1	Antiparasitic Agents (Antiparasitics)IBA 01/2000

Therapy/Procedure

1	Dental Care 11/2004
1	Minor Surgical Procedures (Minor Surgery) 11/2004
1	Therapeutics 01/2004
1	Plasmapheresis 05/2000
1	Organ Transplantation 01/2000